Intravenous free and dipeptide-bound glutamine maintains intestinal microcirculation in experimental endotoxemia

Nutrition

Volumn 28, Issue 5, 2012, Pages 588-593

  Lehmann, Christian ^a,b   Pavlovic, Dragan ^a,c   Zhou, Juan ^b   Wuttke, Ulrich ^a   Saeger, Daniela ^a   Spassov, Alexander ^a   Hung, Orlando ^b   Cerny, Vladimir ^b   Witter, Tobias ^b   Whynot, Sara ^b   Suchner, Ulrich ^d   Alteheld, Birgit ^e   Stehle, Peter ^e   Gründling, Matthias ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Fresenius Kabi Deutschland GmbH   (Germany)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Endotoxemia; Glutamine; Intestine; L Alanyl l glutamine; Leukocyte adhesion; Microcirculation

Indexed keywords

ALANINE; ALANYLGLUTAMINE; ARGININE; ASPARAGINE; CITRULLINE; ENDOTOXIN; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LIPOPOLYSACCHARIDE; LYSINE; METHIONINE; ORNITHINE; PHENYLALANINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENDOTOXEMIA; FLUORESCENCE MICROSCOPY; ILEUM; INTESTINAL MICROCIRCULATION; INTESTINE BLOOD FLOW; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VENULE;

ANIMALS; CAPILLARIES; CELL ADHESION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPEPTIDES; ENDOTOXEMIA; GLUTAMINE; ILEUM; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MICROCIRCULATION; RATS; RATS, INBRED LEW;

ANIMALIA; RATTUS;

EID: 84859214673     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.09.021     Document Type: Article

References (30)

1. Gatt M., Reddy B.S., MacFie J. Bacterial translocation in the critically ill-evidence and methods of prevention. Aliment Pharmacol Ther 2007, 25:741-757.
2. Schmidt H., Martindale R. The gastrointestinal tract in critical illness. Curr Opin Clin Nutr Metab Care 2001, 4:547-551.
3. Deitch E.A. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings?. Surgery 2002, 131:241-244.
4. De-Souza D.A., Greene L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 2005, 33:1125-1135.
5. Wischmeyer P.E. Glutamine: role in gut protection in critical illness. Curr Opin Clin Nutr Metab Care 2006, 9:607-612.
6. Wernerman J. Clinical use of glutamine supplementation. J Nutr 2008, 138:2040S-2044S.
7. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., Chang E.B. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001, 16:398-402.
8. Demirkan A., Savaş B., Melli M. Endotoxin level in ischemia-reperfusion injury in rats: effect of glutamine pretreatment on endotoxin levels and gut morphology. Nutrition 2010, 26:106-111.
9. Fillmann H., Kretzmann N.A., San-Miguel B., Llesuy S., Marroni N., González-Gallego J., et al. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology 2007, 236:217-226.
10. Biolo G., Antonione R., De Cicco M. Glutathione metabolism in sepsis. Crit Care Med 2007, 35(9 suppl):S591-S595.
11. Lyons J., Rauh-Pfeiffer A., Ming-Yu Y., Lu X.M., Zurakowski D., Curley M., et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med 2001, 29:870-877.
12. Fürst P., Stehle P. What are the essential elements needed for the determination of amino acid requirements in humans?. J Nutr 2004, 134:1558S-1565S.
13. Grau T., Bonet A., Miñambres E., Piñeiro L., Irles J.A., Robles A., et al. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 2011, 39:1263-1268.
14. Singer P., Berger M.M., Van den Berghe G., Biolo G., Calder F., Forbes A., et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009, 28:387-400.
15. Cruzat V.F., Tirapegui J. Effects of oral supplementation with glutamine and alanyl-glutamine on glutamine, glutamate, and glutathione status in trained rats and subjected to long-duration exercise. Nutrition 2009, 25:428-435.
16. Pavlovic D., Frieling H., Lauer K.S., Bac V.H., Richter J., Wendt M., et al. Thermostatic tissue platform for intravital microscopy: 'the hanging drop' model. J Microsc 2006, 224:203-210.
17. Fürst P., Pollack L., Graser T., Godel H., Stehle P. Appraisal of four pre-column derivatization methods for the high-performance liquid chromatographic determination of free amino acids in biological materials. J Chromatogr 1990, 499:557-570.
18. Mates J.M., Perez-Gomez C., Nunez de Castro I., Asenjo M., Marquez J. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol 2002, 34:439-458.
19. Lai Y.N., Yeh S.L., Lin M.T., Shang H.F., Yeh C.L., Chen W.J. Glutamine supplementation enhances mucosal immunity in rats with gut-derived sepsis. Nutrition 2004, 20:286-291.
20. Roth E., Oehler R., Manhart N., Exner R., Wessner B., Strasser E., Spittler A. Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 2002, 18:217-221.
21. Scheibe R., Schade M., Grundling M., Pavlovic D., Starke K., Wendt M., et al. Glutamine and alanyl-glutamine dipeptide reduce mesenteric plasma extravasation, leukocyte adhesion and tumor necrosis factor-alpha (TNF-alpha) release during experimental endotoxemia. J Physiol Pharmacol 2009, 60(suppl 8):19-24.
22. Arndt H., Kullmann F., Reuss F., Scholmerich J., Palitzsch K.D. Glutamine attenuates leukocyte-endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat. JPEN 1999, 23:12-18.
23. Hayashi Y., Sawa Y., Fukuyama N., Nakazawa H., Matsuda H. Preoperative glutamine administration induces heat-shock protein 70 expression and attenuates cardiopulmonary bypass-induced inflammatory response by regulating nitric oxide synthase activity. Circulation 2002, 106:2601-2607.
24. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., Chang E.B. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 2001, 90:2403-2410.
25. Singleton K.D., Wischmeyer P.E. Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1839-R1845.
26. Yoo C.G., Lee S., Lee C.T., Kim Y.W., Han S.K., Shim Y.S. Anti-inflammatory effect of heat shock protein induction is related to stabilization of I kappa B alpha through preventing I kappa B kinase activation in respiratory epithelial cells. J Immunol 2000, 164:5416-5423.
27. Xie Y., Chen C., Stevenson M.A., Auron P.E., Calderwood S.K. Heat shock factor 1 represses transcription of the IL-1beta gene through physical interaction with the nuclear factor of interleukin 6. J Biol Chem 2002, 277:11802-11810.
28. Wischmeyer P.E., Riehm J., Singleton K.D., Ren H., Musch M.W., Kahana M., Chang E.B. Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 2003, 19:1-6.
29. Liang M., Wang X., Yuan Y., Zhou Q., Tong C., Jiang W. Different effect of glutamine on macrophage tumor necrosis factor-alpha release and heat shock protein 72 expression in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai) 2009, 41:171-177.
30. Perng W.C., Huang K.L., Li M.H., Hsu C.W., Tsai S.H., Chu S.J., Chang D.M. Glutamine attenuates hyperoxia-induced acute lung injury in mice. Clin Exp Pharmacol Physiol 2010, 37:56-61.